Efficacy of Puls-therapy with Glucocorticoids in Patients with Autoimmune Ophtalmopatay
https://doi.org/10.14341/ket20084344-49
Abstract
The article is presents the results of estimation efficiency of various schemes pathogenetic glucocorticoids treatment of autoimmune ophthalmopathy. Research of clinical parameters dynamics including subjective and objective attributes, proptosis, dynamics of the soluble form of intercellular molecule adhesion-1 levels was made before treatment and at the end of research (in 6 month follow up after complete course of pathogenetic treatment). The study has demonstrated that combination of glucocorticoids pulse-therapy and mean volume plasmapheresis is the most effective pathogenetic method of autoimmune ophthalmopathy treatment; absence of advantages of the used schemes of treatment for reduction proptosis. Advantages of use of the combined therapy are marked in comparison with monotherapy by glucocorticoids at estimation of subjective attributes.
References
1. Бровкина А.Ф. Кортикостероидная терапия в лечении эндокринных офтальмопатий // Белорус. офтальмол. журн. 2002. № 1. С. 38-41.
2. Бровкина А.Ф. Современные аспекты патогенеза и лечения эндокринной офтальмопатии // Вестн. Рос. акад. мед. наук. 2003. № 5. С. 52-54.
3. Бровкина А.Ф. Эндокринная офтальмопатия М.: ГЭОТАРМЕД, 2004. 176 с.
4. Бурса Т.Р. Эндокринная офтальмопатия // Пробл. эндокринол. 1998. Т. 44, № 5. С. 47-54.
5. Родионова Т.И. Патогенез, диагностика и лечение эндокринной офтальмопатии // Пробл. эндокринол. 1997. № 6.С. 46-50.
6. Родионова Т.И. Ранняя диагностика, критерии выбора тактики лечения, прогноз течения аутоиммунной офтальмопатии у больных диффузным токсическим зобом: Автореф. дис.... докт. мед. наук: М., 1998. 34 с.
7. Родионова Т.И. Роль растворимой формы межклеточной молекулы адгезии ICAM-1 в ранней диагностике и оценке эффективности терапии аутоиммунной офтальмопатии у больных диффузным токсическим зобом // Пробл. эндокринол. 1998. Т. 44. №3. С. 16-19.
8. Bartalena L., Pinchera A., Marcocci C. Management of Graves’ ophthalmopathy: Reality and perspectives // Endocrine Rev. 2000. V. 21. N 2. P. 168-199.
9. Devron H.C. The ophthalmopathy of Graves disease // Med. Clin. N. Am. 1991. V. 75. N 2. P. 97-119.
10. Heufelder A.E., Bahn R.S. Soluble intercellular adhesion molecule-(sICAM-1) in sera of patients with Graves’ ophthalmopathy and thyroid diseases // Clin. Exp. Immunol. 1993. V. 92. N 2. P. 296-302.
11. Barbesino G. et. al. Intravenous glucocorticoids are better tolerated and more effective than oral glucocorticoids in adjunct to orbital radiotherapy in severe Graves’ ophthalmopathy: a prospective single-blind randomized study / 5th Eur. Congr. of Endocrinology. Turin, 2001. P. 0-014.
12. Bellis A. et. al. Soluble intercellular adhesion molecule-1 (sICAM-1) concentrations in Graves’ disease patients followed up for development of ophthalmopathy // J. Clin. Endocrinol. Metab. 1998. V. 83. N 4. P. 1222-1225.
13. Kulig G. et. al. Usefulness of soluble ICAM-1 measurements for the evaluation of the disease activity and efficiency of therapy in patients with infiltrative Graves’ ophthalmopathy // Pol. Arch. Med. Wewn. 2002. V. 108. N 6. P. 1161-1169.
14. Wiersinga W.M., Prummel M.F. An evidence-based approach to the treatment of Graves’ ophthalmopathy // Endocrinology and metabolism clinics of North America. 2000. V. 29. N 2. P. 297-319.
15. Wiersinga, W.M. Graves’ ophthalmopathy // Thyroid Int. 1997. V. 3. P. 3-15.
16. Wiersinga W.M., Prummel M.F. Graves’ ophthalmopathy: a rational approach treatment // Clinical case studies in endocrinology: 10th EFES Postgraduate clinical endocrinology course, Riga, 29-31 May 2003. Riga, 2003. P. 19-25.
Review
For citations:
, Efficacy of Puls-therapy with Glucocorticoids in Patients with Autoimmune Ophtalmopatay. Clinical and experimental thyroidology. 2008;4(3):44-49. (In Russ.) https://doi.org/10.14341/ket20084344-49
Views:
326
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
